Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity
Liu C. et al, (2024), Cell Reports Medicine, 5, 101553 - 101553
Tracking in situ checkpoint inhibitor-bound target T cells in patients with checkpoint-induced colitis
Gupta T. et al, (2024), Cancer Cell, 42, 797 - 814.e15
Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases
Lippert AH. et al, (2024), Immunity, 57, 256 - 270.e10
The paralogues MAGOH and MAGOHB are oncogenic factors in high-grade gliomas and safeguard the splicing of cell division and cell cycle genes
Barreiro RAS. et al, (2023), RNA Biology, 20, 311 - 322
The current state and future of T-cell exhaustion research
Jenkins E. et al, (2023), Oxford Open Immunology, 4
Combination CD200R/PD-1 blockade in a humanised mouse model
Fellermeyer M. et al, (2023), Immunotherapy Advances, 3
LARP1 isoform expression in human cancer cell lines
Schwenzer H. et al, (2021), RNA Biology, 18, 237 - 247
Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumor fate
Jostes SV. et al, (2020), International Journal of Cancer, 146, 1592 - 1605
The bromodomain inhibitor JQ1 triggers growth arrest and apoptosis in testicular germ cell tumoursin vitroandin vivo
Jostes S. et al, (2017), Journal of Cellular and Molecular Medicine, 21, 1300 - 1314
SOX2 is essential for in vivo reprogramming of seminoma-like TCam-2 cells to an embryonal carcinoma-like fate
Nettersheim D. et al, (2016), Oncotarget, 7, 47095 - 47110